ArticleBMC cancer2026

Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutaneous melanoma.

Patric Ejder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.